Results for technologies (2)
Advanced filter
MMP14 targeting natural antibodies to treat ovarian cancer (No. T4-2152)
Ovarian cancer is the fifth leading cause of cancer-related death in women. Due to a lack of early detection methods, it is often diagnosed at a late stage, resulting in negligible changes to cure.
Ovarian carcinoma is the most lethal gynecological malignancy and the fifth leading...
Read more
17825
Anti-LOX for the Treatment of Duchenne, Fibrosis and Cancer (No. T4-1913)
Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years.
Duchenne muscular dystrophy (DMD) is a disease that causes progressive muscle weakness, loss of skeletal and heart muscle tissue, degeneration, and eventu...
Read more
6026